Science Portal

Human genetics: what the field investigates and how a report is produced

October 3, 2026approx. 15 minutesby mybody®x Editorial & Expert Team

Humangenetik: was das Fach untersucht und wie ein Befund entsteht

Key points

Human genetics is a distinct field of medicine that investigates genetically determined conditions and advises those affected (GfH/BVDH, as of 2018). Genetic testing involves more than a lab test: in statutory health insurance practice, it includes providing information and obtaining consent, according to the KBV (2024), and concludes with a written report interpreting the results.

Cytogenetics examines entire chromosomes, while molecular genetics looks for changes in one or more genes, according to MedlinePlus Genetics (NLM, 2021).

As a guideline, microarray analysis, which scans the genome for small missing or duplicated sections, takes 4 to 8 weeks at most to produce a report, provided no further investigations are needed (GfH/BVDH, as of 2018).

The report should also be understandable to doctors without specialist knowledge of human genetics and should answer the question being investigated (GfH/BVDH, as of 2018).

In this article

What is human genetics, and who provides counseling?

Human genetics is a distinct field of human medicine: it determines whether a genetic change is responsible for or contributes to a condition (GfH/BVDH, as of 2018). In general, only doctors with a specific qualification may provide genetic counseling independently (GfH/BVDH, as of 2018).

Perhaps a doctor has mentioned genetic testing, or a condition occurs several times in your family. In that case, it helps to know what the field covers before making an appointment.

The main reference for this article is the guideline “Human Genetic Diagnostics and Genetic Counseling” issued by the German Society of Human Genetics and the Professional Association of German Human Geneticists (GfH/BVDH, as of 2018). It applies to diagnostic and predictive genetic testing, including prenatal testing. It is a recommendation from professional societies, not a legal regulation. The guideline’s own wording shows how it describes the field.

Cited source

“Human genetics is a distinct field of human medicine that combines clinical, counseling, and laboratory diagnostic expertise.”

German Society for Human Genetics and Professional Association of German Human Geneticists
AWMF guideline 078-015 (GfH/BVDH, as of 2018)

Genetic disorders occur in every area of medicine, which is why human genetics works closely with other specialties (GfH/BVDH, as of 2018). In addition to laboratory methods, diagnostic work includes clinical and biochemical examinations. According to MedlinePlus Genetics (NLM, 2021), biochemical tests do not examine the DNA itself, but rather the amount or activity of proteins and enzymes produced according to the genes’ instructions.

There is a clear qualification requirement for counseling. As a rule, independent genetic counseling requires qualification as a specialist in human genetics or an additional qualification in medical genetics, which specialists in other fields can also obtain (GfH/BVDH, as of 2018). This is distinct from specialty-specific genetic counseling: specialists in other fields provide it within their own specialty when requesting a genetic test. According to the KBV (2024), 72-hour courses are offered to obtain this qualification in statutory health insurance care.

In the laboratory, the field distinguishes tests by the size of what they look for. Cytogenetics examines chromosomes as a whole, while molecular genetics examines the DNA of individual genes. In between is molecular cytogenetics: the regions detected this way are “often significantly smaller than those detectable using cytogenetic methods and larger than those that can be represented using molecular genetic methods” (GfH/BVDH, as of 2018).

If you have a specific question about a condition in your family, it belongs in a genetic counseling session: the article on genetic counseling describes step by step what happens during the session; here, we focus on the field and the path from the laboratory to the findings.

What diseases does human genetics investigate?

Human genetics deals with rare disorders, which occur in fewer than 1 in 2,000 people, as well as common disorders with a genetic component (GfH/BVDH, as of 2018). In the laboratory, changes can be broadly classified according to whether they affect entire chromosomes or individual genes.

Chromosomal changes are the broadest level. According to MedlinePlus Genetics (NLM, 2021), chromosome studies examine entire chromosomes or long stretches of DNA and detect major changes. These include an extra chromosome, called trisomy, or a missing one, called monosomy. A large piece of a chromosome can also be duplicated (duplication) or missing (deletion). These studies also reveal rearrangements of chromosome segments, known as translocations.

Another group is caused by a single gene. According to MedlinePlus Genetics (NLM, 2021), some genetic conditions are caused by variants in a single gene; a variant is a change in DNA, also called a mutation. Such conditions are usually inherited according to one of several patterns, depending on the gene involved (NLM, 2021). In a dominant inheritance pattern, one altered copy of the gene in each cell is enough; in a recessive pattern, both copies carry a variant (NLM, 2021). The article on dominant and recessive inheritance patterns explains how these patterns work in detail.

Not every condition with a genetic component follows this pattern. According to MedlinePlus Genetics (NLM, 2021), many conditions arise from the interaction of several genes, known as polygenic inheritance, or from interactions between genes and the environment. They generally do not follow the inheritance patterns described here (NLM, 2021).

Whether an appointment in human genetics may be appropriate for you depends on the reason. The article on the line between DNA testing and disease risk explains what those reasons might be.

Which laboratory methods are used in human genetics?

Human genetics uses methods with different levels of resolution, ranging from whole chromosomes under a microscope to individual DNA variants. According to MedlinePlus Genetics (NLM, 2021), which method is appropriate depends on the suspected condition and the genetic changes typically associated with it.

You can think of the procedures as maps at different scales: one shows entire countries, while another shows individual house numbers. If the diagnosis is unclear, a test that covers many genes or chromosomes can be used; when there is a specific suspicion, a more targeted test may be appropriate (NLM, 2021).

Chromosome analysis is the cytogenetic examination of chromosomes under a microscope. After birth, it examines a blood sample, a tissue sample, a cell smear, or a cell culture from body tissue (GfH/BVDH, as of 2018). As a minimum standard, around 400 bands per haploid, or single, chromosome set should be achieved; for certain questions, at least 550 (GfH/BVDH, as of 2018). Bands are the sections visible on chromosomes after standard staining; the figure refers to this staining (GfH/BVDH, as of 2018).

The microarray analysis provides finer resolution. It searches genome-wide, across the entire genome, and at high resolution for microdeletions and microduplications, small missing or duplicated sections (GfH/BVDH, as of 2018). As a guide to turnaround time, results take 4 to no more than 8 weeks after the sample is received if no further investigations are needed, and 8 to no more than 12 weeks if additional material from the parents is also tested (GfH/BVDH, as of 2018). These timeframes apply only to the microarray.

According to MedlinePlus Genetics (NLM, 2021), molecular genetics looks for changes in one or more genes. The most targeted approach is testing for a specific variant or a single gene. A gene panel, by contrast, tests for variants in more than one gene; according to MedlinePlus Genetics (NLM, 2021), it is often used when symptoms are consistent with many conditions or when the suspected condition may be caused by variants in many genes (NLM, 2021).

The next step is sequencing, or reading the DNA sequence: exome sequencing goes beyond a gene panel, while genome sequencing covers the entire genome. Exome or genome sequencing is typically used when single-gene or panel tests have not yielded a diagnosis or when the cause is unclear (NLM, 2021).

Methods that generate large amounts of data raise a question of their own. Before a gene panel or exome sequencing, patients must be explicitly informed about potentially uninterpretable findings and secondary findings (GfH/BVDH, as of 2018). Secondary findings are results beyond the original purpose of the test. Under the guideline of the Genetic Diagnostics Commission (RKI, 2023), which applies to genetic counseling by physicians in diagnostic and predictive contexts under the Genetic Diagnostics Act, including prenatal contexts, such incidental findings may only be disclosed if the person concerned explicitly wishes to receive them and the result is sufficiently likely to have clinical significance.

Overview of human genetic laboratory methods

Method What it shows What to know
Chromosome analysis Whole chromosomes, such as an extra or missing chromosome (NLM, 2021) Minimum standard of about 400 bands per haploid chromosome set (GfH/BVDH, as of 2018)
Microarray analysis Small missing or duplicated sections, searched across the entire genome Guideline: 4 to 8 weeks at most without further investigation (GfH/BVDH, as of 2018)
Single gene or single variant Changes at a specific location or in a specific gene Targeted test for a specific suspected condition (NLM, 2021)
Gene panel Variants in more than one gene (NLM, 2021) Prior counseling about uninterpretable findings and additional findings (GfH/BVDH, as of 2018)
Exome or genome Variants beyond a gene panel; for the genome, across the entire genetic material In a statutory health insurance practice, exome analysis always carries the possibility of findings outside the relevant specialty; in that case, a specialist in human genetics is involved (KBV, 2024)

Sources: GfH and BVDH (GfH/BVDH, as of 2018) and MedlinePlus Genetics (NLM, 2021); the row on exome analysis applies to statutory health insurance practices (KBV, 2024).

How does a human genetic test work?

In a statutory health insurance practice, a genetic test includes indication, counseling, consent, genetic counseling if necessary, and laboratory analysis—in other words, the actual genetic test—according to the KBV (2024). In statutory health insurance care, in-person contact between the physician and the patient is always required (KBV, 2024).

White lab coat on a light wooden chair, cotton balls in a dark bowl, and a glass of water

So the objection “They’re only taking a blood sample” is only partly right. The sample is the starting point for the laboratory analysis, but a consultation and decision come first. This refers to testing as defined by the Genetic Diagnostics Act, which, according to the KBV (2024), applies to human genetic testing for medical purposes; the article on genetic analysis explains what the law covers and who may order the test.

It starts with the indication, meaning the medical reason for the test. This is followed by counseling and consent. Whether genetic counseling is required before the laboratory analysis depends on the individual case in a statutory health insurance practice: the KBV (2024) specifies that it is required “if necessary.”

The laboratory is commissioned in a statutory health insurance practice using referral form Muster 10 (KBV, 2024). It bears the responsible physician’s stamp and signature, as described by the KBV (2024) for statutory health insurance care: this is the physician who performs the genetic test, and only they may order the laboratory analysis. They also receive the result and share it with you.

The responsible physician also ensures that the results are retained for ten years; this is how the KBV (2024) describes the requirement for statutory health insurance practices.

According to the KBV (2024), a human genetic examination covered by statutory health insurance is permitted for people with statutory insurance only if both conditions are met: the service is listed in the Uniform Value Scale (EBM), the catalog of reimbursable services, and there is a medical indication. The article Genetic Testing and Health Insurance explains whether a genetic test is considered diagnostic or predictive and what that means for insurance coverage.

Chapter at a glance

In statutory health care, according to the KBV (2024), a human genetic examination consists of a consultation and laboratory testing, not a single test. The indication and consent are established before the laboratory analysis. In statutory health care, the laboratory is commissioned using Form 10 (KBV, 2024); the result is sent to the responsible physician, who informs you. In statutory health care, results are retained for ten years (KBV, 2024).

How is a human genetic report structured?

The written laboratory report communicates the result to the referring physician and should also be understandable without specialized knowledge in human genetics (GfH/BVDH, as of 2018). After genetic counseling, you will also receive a separate letter containing the human geneticist’s assessment.

A report is more than a test result: it interprets the result in light of the question that led to the examination. The result and conclusions should be clearly highlighted, and the diagnostic question should be answered (GfH/BVDH, as of 2018). The report includes, among other things, the following information (GfH/BVDH, as of 2018).

What a laboratory report contains

Sample which sample was submitted, such as blood or DNA

Clinical question the diagnosis or suspected diagnosis and the reason for the examination

Method and scope which method was used and which genes were examined

Result briefly and clearly stated as a genotype, meaning the identified genetic variant, using the internationally recognized HGVS nomenclature

Interpretation an assessment of the clinical significance, tailored to the specific clinical question

Diagnostic significance if applicable, a note that the findings are of limited diagnostic significance

Where necessary, the report recommends genetic counseling and explains what the result may mean for the person tested and their family (GfH/BVDH, as of 2018).

A different letter is intended for you. An integral part of genetic counseling is a written human genetic assessment, which presents the counseling and its results in plain language (GfH/BVDH, as of 2018). A clear structure and a brief summary are recommended (GfH/BVDH, as of 2018). Medical terms should be explained or described in other words as far as possible. For people with statutory health insurance, the guideline, which is a recommendation by professional associations and not a legal requirement, also calls for a report to the referring specialist or primary care practice; it may be omitted at your express request (GfH/BVDH, as of 2018).

A finding is more than a test result: it interprets the result in relation to the question that led to the examination.

Is a DNA predisposition test human genetic diagnostics?

No. According to MedlinePlus Genetics (NLM, 2021), direct-to-consumer genetic tests typically examine a number of specific variants in particular genes rather than identifying all variants in those genes.

The Longevity | ALL IN ONE DNA test from mybody®x (MYBODY Lab GmbH) analyzes more than 170 genetic variations from a saliva sample and costs €369.00 (as of 03.10.2026); prices may change. It analyzes selected SNPs, or individual inherited sections of DNA. The method is SNP genotyping, which checks predetermined individual positions, not whole-genome sequencing, which reads the entire genome. It is not a medical examination and does not provide a diagnosis.

A predisposition is not a certainty, but a description of what you have to work with. In human genetics, this means that a predisposition report does not replace medical genetic testing or genetic counseling. If you have a question about a disease, you need the approach described in the previous chapters, because this test does not provide information about diseases.

A gene panel or exome sequencing, by contrast, specifically looks for the cause of a disease (NLM, 2021). The article Genotyping or sequencing explains the technical differences between genotyping and sequencing.

Limitations: What remains unresolved in human genetic diagnostics?

The significance of a variant that is found may remain unclear. In genome-wide analyses, variants of uncertain significance (VUS) are “numerous to be expected,” according to the guideline of the Genetic Diagnostics Commission (RKI, 2023); it applies to genetic counseling by doctors in diagnostic and predictive contexts under the Genetic Diagnostics Act, including prenatal contexts.

A variant of uncertain significance is a change whose impact on health cannot be determined with certainty. The report may also include a note indicating that its findings are limited in scope (GfH/BVDH, as of 2018). This is exactly what patients are informed about before procedures involving large amounts of data.

The timeframe given in the methods chapter applies only to microarray analysis (GfH/BVDH, as of 2018). The guideline itself applies to diagnostic and predictive genetic testing, including prenatal diagnostics; tests conducted for other purposes are not covered by its provisions (GfH/BVDH, as of 2018). A review was planned for December 2023 (GfH/BVDH, as of 2018); its validity has since expired.

The process described, using Form 10 and a responsible doctor, applies to statutory health insurance care, that is, practice under the statutory health insurance system (KBV, 2024).

What can you gain from learning about human genetics before an appointment?

It helps you ask more focused questions at your appointment: which method is suitable for your question, and what the final report is meant to answer. The statement “They just take a blood sample” describes only one step; the conversation comes before the sample, and interpretation comes after the lab work. A genetic test provides a result. The report is what turns it into an answer to your question.

Frequently asked questions

What sample does human genetics need?

That depends on the method and the question being investigated. For chromosome analysis after birth, the range of samples extends from a blood sample to a cell culture from body tissue (GfH/BVDH, as of 2018). The written report later states explicitly what material was submitted, for example blood or DNA that has already been extracted (GfH/BVDH, as of 2018). But the sample alone does not constitute a test: According to the KBV (2024), in statutory health insurance practice, this includes providing information and obtaining consent, and personal contact with the doctor is always required.

Does human genetics only examine changes present from birth?

No. Genetic changes can be present from birth, known as germline mutations, or develop over the course of life, for example as somatic mutations in body cells (GfH/BVDH, as of 2018). In the latter case, they are present only in a group of cells or in a tissue. Diagnostics covers both forms: it looks for a genetic change, either present from birth or acquired, that could be the cause of a disease or a risk factor for it (GfH/BVDH, as of 2018).

Why does human genetics ask about the family?

Because relatives' medical histories may be relevant to interpreting the results: In addition to your own medical history, a family history covering at least three generations may be useful, according to the guideline of the Genetic Diagnostics Commission (RKI, 2023), which applies to genetic counseling by physicians in diagnostic and predictive contexts under the Genetic Diagnostics Act, including prenatal testing. A family history means asking about illnesses in the family. The written human genetics report summarizes it across at least three generations (GfH/BVDH, status 2018). The laboratory report also includes personal and family medical history insofar as it is relevant to the question at hand (GfH/BVDH, status 2018).

Will my relatives learn about my human genetic test results?

Not without consent. In statutory health insurance practice, the responsible physician may communicate the results to other people only with the affected person's express written consent, according to the KBV (2024). Under the professional societies' guideline, a recommendation for diagnostic and predictive genetic testing, including prenatal diagnosis, information and findings concerning relatives may be shared only with their consent, and they must not be contacted without their explicit wish (GfH/BVDH, status 2018). Instead, the practice can give you information to pass on to your relatives, for example in the form of a “family letter” (GfH/BVDH, status 2018).

Can I withdraw my consent to human genetic testing?

Yes. In statutory health insurance practice, consent to genetic testing may be withdrawn at any time with effect for the future, according to the KBV (2024). The withdrawal must be addressed to the responsible physician, that is, the doctor who performs the test and is the only person authorized to request the laboratory analysis. In statutory health care, this same person also receives the results and communicates them to you (KBV, 2024).

Next step

Understanding genetic counseling in human genetics

The next article explains how a counseling session works, step by step, and what its purpose is.

How genetic counseling works Genetics for Beginners Take your time to review the basic terms of genetics

Read more

Sources

  1. German Society of Human Genetics and Professional Association of German Human Geneticists: S2k Guideline on Human Genetic Diagnostics and Genetic Counseling, AWMF 078-015 (GfH/BVDH, as of 2018) – register.awmf.org
  2. National Association of Statutory Health Insurance Physicians: PracticeInfoSpecial Genetics (KBV, 2024) – kbv.de
  3. Genetic Diagnostics Commission: Guideline on Genetic Counseling (RKI, 2023) – rki.de
  4. MedlinePlus Genetics: What are the different types of genetic tests? (NLM, 2021) – medlineplus.gov

[1] supports the information on the field and laboratory methods, as well as the structure of the findings and statement. [2] describes the examination process and the cost rules for statutory health insurance coverage. [3] supports the statements on incidental findings and variants of uncertain significance. [4] supports the types of genetic tests; the inheritance patterns are from the same resource, page What are the different ways a genetic condition can be inherited? (NLM, 2021). Price and product details for the mybody®x DNA test: information current as of 03.10.2026. All sources were accessed on 03.10.2026.

mybody®x (MYBODY Lab GmbH) Certificate / Quality Seal

mybody®x Editorial & Expert Team

Human genetics Genetic testing

The mybody®x editorial and expert team makes specialist sources on genetics easy to understand; every figure in the text is accompanied by its source and year. Find out more about the team on the authors page.

Published on 03.10.2026 · Last updated on 03.10.2026

The content is for general information and does not replace medical advice, diagnosis, or treatment.

Our products are not intended to diagnose, treat, cure, or prevent diseases.

DNA analysis is intended to provide nutritional and lifestyle advice. It is not a diagnostic procedure, does not predict diseases, and does not replace medical examination or advice. Genetic variants describe probabilities in population groups, not certainties for individuals.

The images in this article were created using AI; the people shown are not real.

mybody®x (MYBODY Lab GmbH) Certificate / Quality Seal

Read more

Latest posts

View all